Burlingame, Oct. 09, 2024 (GLOBE NEWSWIRE) — The global skin rash treatment market Size to Grow from USD 3.67 billion in 2024 to USD 5.70 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period, as highlighted in a new report published by Coherent Market Insights. Growing geriatric population is also expected to drive market growth as skin conditions are highly prevalent among the older population. Meanwhile, ongoing research and development activities for developing more effective treatment regimens are estimated to offer lucrative market opportunities over the forecast period.

Request Sample of the Report on Skin Rash Treatment Market Forecast 2031: https://www.coherentmarketinsights.com/insight/request-sample/6688

Market Dynamics

The skin rash treatment market is expected to witness significant growth over the forecast period. Rising incidences of various skin diseases such as eczema, psoriasis and dermatitis are expected to propel the demand for skin rash treatment products.

According to American Academy of Dermatology, over 50 million Americans suffer from eczema every year. Furthermore, new product launches by the key players are also anticipated to boost the market growth during the analysis period.

Skin Rash Treatment Market Report Coverage

Market Trends

Increasing adoption of natural and herbal products for skin rash treatment is projected to create lucrative opportunities for market players during the forecast period. For instance, Dead Sea products or aloe vera creams are widely used for skin rash treatment.

Rising consumer awareness regarding the side effects of synthetic products is further expected to fuel the demand for organic and natural skin rash treatment products.

Moreover, surge in online purchase of skin rash treatment products owing to easy availability and convenience is also estimated to support the market growth over the coming years.

Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6688

Market Segmentations

Corticosteroids Treatment: Corticosteroids are expected to hold the largest share of the skin rash treatment market during the forecast period. Corticosteroids work by reducing inflammation and itching caused by skin conditions like eczema, psoriasis, and hives.

Immunosuppressants Treatment: Immunosuppressants are projected to witness the highest growth in the skin rash treatment market. Conditions like eczema that cause chronic inflammation can sometimes become resistant to conventional corticosteroid treatment.

Key Market Takeaways

The global skin rash treatment market size is anticipated to witness a CAGR of 6.5% during the forecast period 2024-2031. Due to the high and growing prevalence of skin rashes across all age groups.

On the basis of treatment type, the corticosteroids segment is expected to hold a dominant position, owing to their widespread adoption as first-line therapy due to effectiveness and easy availability.

Based on skin rash type, the contact dermatitis segment is anticipated to lead the market, as it is one of the most common types of skin rashes caused by various allergens and irritants.

By distribution channel, hospital pharmacies are projected to dominate the market since patients often require prescription medications which are conveniently available at these medical facilities.

Regionally, North America is expected to hold the largest share over the forecast period, due to the rising awareness about skin diseases, developed healthcare infrastructure, and presence of major players.

Competitor Insights

Key players in the skin rash treatment market include:

• Amgen
• Sun Pharmaceutical Industries
• Teva Pharmaceuticals Industries
• Eli Lilly and Company
• Mylan N.V
• Johnson & Johnson
• Leo Pharma
• Novartis AG
• AbbVie
• Merck & Co.

Skin Rash Treatment Industry News

In April 2024, Dermavant Announces U.S. FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 years and older.

In January 2024, Pfizer and Glenmark launched a new atopic dermatitis drug, abrocitinib, which has received marketing authorization from the Central Drugs Standard Control Organization in India and approval from the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/6688

Detailed Segmentation:

By Treatment Type:

• Corticosteroids
• Immunosuppressants
• Antihistamines
• Antifungals
• Others

By Skin Rash Type:

• Contact Dermatitis
• Atopic Dermatitis
• Psoriasis
• Seborrheic Dermatitis
• Others

By Distribution Channel:

• Pharmacies
• Retail Stores
• Others (Hypermarkets, etc.)

By Region:

• North America
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa

Have a Look at Trending Research Reports on Pharmaceutical Domain:

Global Barth Syndrome Treatment Market is estimated to be valued at USD 141.10 billion in 2024 and is expected to reach USD 336.11 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.

Global over the counter pain medication market is estimated to be valued at USD 27.12 Bn in 2024 and is expected to reach USD 35.50 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.

Global online therapy services market is estimated to be valued at USD 9.68 Bn in 2024 and is expected to reach USD 24.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.4% from 2024 to 2031.

Global joint pain injections market is estimated to be valued at USD 5.29 Bn in 2024 and is expected to reach USD 9.46 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedIn | Twitter

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights

Phone:
US: +1-650-918-5898
UK: +44-020-8133-4027
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com